RT @davidleonjimene: https://t.co/gw9Z6x3aCa EL NHE3 va a dar mucho que hablar
RT @davidleonjimene: https://t.co/gw9Z6x3aCa EL NHE3 va a dar mucho que hablar
RT @DiabetologiaJnl: Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ucLqr1
RT @DiabetologiaJnl: Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ucLqr1
RT @DiabetologiaJnl: Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ucLqr1
RT @DiabetologiaJnl: Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ucLqr1
Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ucLqr1
https://t.co/gw9Z6x3aCa EL NHE3 va a dar mucho que hablar
RT @DiabetologiaJnl: Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ud31iz
RT @DiabetologiaJnl: Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ud31iz
Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ud31iz
RT @DiabetologiaJnl: Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ud31iz
More evidence to impact clinical prescribing? https://t.co/JyGHAUVC7q
RT @DiabetologiaJnl: Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ud31iz
Empagliflozin has direct cardiac effects through lowering of cytoplasmic Na+ https://t.co/jOQ1ud31iz
RT @DanielJDrucker: Does #empagliflozin modulate cardiac ion flux independent #SGLT2? Do off target mechanisms prevail? @DiabetologiaJnl ht…
RT @DanielJDrucker: Does #empagliflozin modulate cardiac ion flux independent #SGLT2? Do off target mechanisms prevail? @DiabetologiaJnl ht…
Does #empagliflozin modulate cardiac ion flux independent #SGLT2? Do off target mechanisms prevail? @DiabetologiaJnl https://t.co/2X83F4pWxb